Three-dimensional evaluation of chemotherapy response in malignant pleural mesothelioma
- 30 April 2010
- journal article
- Published by Elsevier in European Journal of Radiology
- Vol. 74 (1) , 130-135
- https://doi.org/10.1016/j.ejrad.2009.02.002
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Randomized Phase III Study of Cisplatin With or Without Raltitrexed in Patients With Malignant Pleural Mesothelioma: An Intergroup Study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of CanadaJournal of Clinical Oncology, 2005
- Malignant mesotheliomaThe Lancet, 2005
- Chemotherapy for malignant pleural mesothelioma: past results and recent developmentsLung Cancer, 2004
- Modified RECIST criteria for assessment of response in malignant pleural mesotheliomaAnnals of Oncology, 2004
- Inadequacy of the RECIST criteria for response evaluation in patients with malignant pleural mesotheliomaLung Cancer, 2004
- Inadequacy of the new Response Evaluation Criteria in Solid Tumors (RECIST) in patients with malignant pleural mesothelioma: report of four casesLung Cancer, 2004
- Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural MesotheliomaJournal of Clinical Oncology, 2003
- Malignant Mesothelioma due to Environmental Exposure to AsbestosChest, 2002
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- Reporting results of cancer treatmentCancer, 1981